Recent insights into human coronary collateral development

Heart

Volumn 90, Issue 3, 2004, Pages 246-250

  Fujita, M ^a   Tambara, K ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; GLYCERYL TRINITRATE; HEPARIN; ISOSORBIDE DINITRATE; RECOMBINANT FIBROBLAST GROWTH FACTOR; RECOMBINANT VASCULOTROPIN; SARPOGRELATE; SEROTONIN ANTAGONIST; VASCULOTROPIN; VASODILATOR AGENT;

AGE DISTRIBUTION; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ANGIOGENESIS; ARTERY LESION; CELL PROLIFERATION; CLINICAL TRIAL; COLLATERAL CIRCULATION; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DISEASE SEVERITY; DRUG EFFECT; DRUG POTENCY; EXERCISE; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE PERFUSION; HEART MUSCLE REPERFUSION; HEART WORK; HUMAN; HYPERCHOLESTEROLEMIA; NONHUMAN; OXYGEN SUPPLY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; ST SEGMENT DEPRESSION; VASODILATATION;

EID: 1342301532     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2002.007989     Document Type: Review

References (40)

1. Lee JS, Feldman AM. Gene therapy for therapeutic myocardial angiogenesis: a promising synthesis of two emerging technologies. Nat Med 1998;4:739-42.
2. Simons M, Bonow RO, Chronos NA, et al. Clinical trials in coronary angiogenesis: issues, problems, consensus. Circulation 2000;102:e73.
3. Schaper W, Buschmann I. Arteriogenesis, the good and bad of it. Eur Heart J 1999;20:1297-9.
4. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389-95.
5. Hershey JC, Baskin EP, Glass JD, et al. Revascularization in the rabbit hindlimb: dissociation between capillary sprouting and arteriogenesis. Cardiovasc Res 2001;49:618-25.
6. Pijls NH, van Son JA, Kirkeeide RL, et al. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 1993;87:1354-67.
7. Piek JJ, van Liebergen RA, Koch KT, et al. Pharmacological modulation of the human collateral vascular resistance in acute and chronic coronary occlusion assessed by intracoronary blood flow velocity analysis in an angioplasty model. Circulation 1997;96:106-15.
8. Seiler C, Fleisch M, Billinger M, et al. Simultaneous intracoronary velocity-and pressure-derived assessment of adenosine-induced collateral hemodynamics in patients with one-to two-vessel coronary artery disease. J Am Coll Cardiol 1999;34:1985-94.
9. Sasayama S, Fujita M. Recent insights into coronary collateral circulation. Circulation 1992;85:69-76.
10. Sabia PJ, Powers ER, Ragosta M, et al. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med 1992;327:1825-31.
11. Cribier A, Korsatz L, Koning R, et al. Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: a prospective study. J Am Coll Cardiol 1992;20:578-86.
12. Fujita M, Yamanishi K, Inoko M, et al. Preferential dilation of recipient coronary arteries of the collateral circulation by intracoronary administration of nitroglycerin. J Am Coll Cardiol 1994;24:631-5.
13. Ohno A, Fujita M, Miwa K, et al. Importance of coronary collateral circulation for increased treadmill exercise capacity by nitrates in patients with stable effort angina pectoris. Cardiology 1991;78:323-8.
14. Tanaka T, Fujita M, Nakae I, et al. Improvement of exercise capacity by sarpogrelate as a result of augmented collateral circulation in patients with effort angina. J Am Coll Cardiol 1998;32:1982-6.
15. Cohen M, Sherman W, Rentrop KP, et al. Determinants of collateral filling observed during sudden controlled coronary artery occlusion in human subjects. J Am Coll Cardiol 1989;13:297-303.
16. Pohl T, Seiler C, Billinger M, et al. Frequency distribution of collateral flow and factors influencing collateral channel development: functional collateral channel measurement in 450 patients with coronary artery disease. J Am Coll Cardiol 2001;38:1872-8.
17. Fujita M, Ikemoto M, Kishishita M, et al. Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina. Circulation 1996;94:610-3.
18. Nolewajka AJ, Kostuk WJ, Rechnitzer PA, et al. Exercise and human collateralization: an angiographic and scintigraphic assessment. Circulation 1979;60:114-21.
19. Ehsani AA, Heath GW, Hagberg JM, et al. Effects of 12 months of intense exercise training on ischemic ST-segment depression in patients with coronary artery disease. Circulation 1981;64:1116-24.
20. Fujita M. Heparin and angiogenic therapy. Eur Heart J 2000;21:270-4.
21. Tateno S, Terai M, Niwa K, et al. Alleviation of myocardial ischemia after Kawasaki disease by heparin and exercise therapy. Circulation 2001;103:2591-7.
22. Nakae I, Fujita M, Miwa K, et al. Age-dependent impairment of coronary collateral development in humans. Heart Vessels 2000;15:176-80.
23. Abaci A, Oguzhan A, Kahraman S, et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 1999;99:2239-42.
24. Waltenberger J, Lange J, Kranz A. Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: a potential predictor for the individual capacity to develop collaterals. Circulation 2000;102:185-90.
25. Melidonis A, Tournis S, Kouvaras G, et al. Comparison of coronary collateral circulation in diabetic and nondiabetic patients suffering from coronary artery disease. Clin Cardiol 1999;22:465-71.
26. Van Belle E, Rivard A, Chen D, et al. Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. Circulation 1997;96:2667-74.
27. Yamanishi K, Fujita M, Ohno A, et al. Importance of myocardial ischaemia for recruitment of coronary collateral circulation in dogs. Cardiovasc Res 1990;24:271-7.
28. Sabri MN, DiSciascio G, Cowley MJ, et al. Coronary collateral recruitment: functional significance and relation to rate of vessel closure. Am Heart J 1991;121:876-80.
29. Fujita M, Nakae I, Fudo T, et al. Fate of collateral vessels after successful coronary angioplasty in patients with effort angina. J Am Coll Cardiol 1997;29:544-8.
30. Werner GS, Ferrari M, Betge S, et al. Collateral function in chronic total coronary occlusions is related to regional myocardial function and duration of occlusion. Circulation 2001;104:2784-90.
31. Freedman SB, Isner JM. Therapeutic angiogenesis far ischemic cardiovascular disease. J Mol Cell Cardiol 2001;33:379-93.
32. Simons M, Annex BH, Laham RJ, et al. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth Tactor-2: double-blind, randomized, controlled clinical trial. Circulation 2002;105:788-93.
33. Henry TD, Annex BH, McKendall GR, et al. The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 2003;107:1359-65.
34. Winbury MM, Howe BB, Hefner MA. Effect of nitrates and other coronary dilators on large and small coronary arteries: a hypothesis for the mechanism of action of nitrates. J Pharmacol Exp Ther 1969;168:70-95.
35. Scheel KW, Galindez TA, Cook B, et al. Changes in coronary and collateral flows and adequacy of perfusion in the dog following one and three months of circumflex occlusion. Circ Res 1976;39:654-8.
36. Scheel KW, Wilson JL, Ingram LA, et al. The septal artery and its collaterals in dogs with and without circumflex occlusion. Am J Physiol 1980;238:H504-14.
37. Seiler C, Pohl T, Wustmann K, et al. Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation 2001;104:2012-7.
38. Rockstroh J, Brown BG. Coronary collateral size, flow capacity, and growth: estimates from the angiogram in patients with obstructive coronary disease. Circulation 2002;105:168-73.
39. Kamihata H, Matsubara H, Nishiue T, et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 2001;104:1046-52.
40. Kawamoto A, Tkebuchava T, Yamaguchi J, et al. Intramyocardial transplantation of autalogous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 2003;107:461-8.